权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Mentoring patient-oriented researchers in inflammatory airway disease

指导炎症性气道疾病领域以患者为中心的研究人员

基本信息

批准号：
10515489
负责人：
TAYLOR A DOHERTY
金额：
$ 19.37万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN DIEGO
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
起止时间：
2022-07-01 至 2027-06-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10515489
关键词：
ACVR1 gene Affect Airway Disease Allergic Allergic Disease Allergic rhinitis Animal Model Aspirin Asthma Award Bioinformatics Biological Biological Products Biological Response Modifier Therapy Blood Cellular biology Chronic Clinic Clinical Clinical Investigator Clinical Trials Cluster Analysis Coculture Techniques Color Conduct Clinical Trials Discipline Disease Eicosanoids Eosinophilic Esophagitis Epithelial Cells Faculty Flow Cytometry Fostering Funding Future Goals Health Care Costs Human Hypersensitivity Immunology In Vitro Individual Inflammation Inflammatory Interleukin 4 Receptor Interleukin-13 Interleukin-4 Interleukin-5 Laboratories Lead Letters Leukocytes Lipids Lung Lymphoid Cell Mediating Mentors Mentorship Mid-Career Clinical Scientist Award (K24)Migration Assay Mission Morbidity - disease rate Nasal Polyps Nature Nose Otolaryngology Pathogenesis Pathway interactions Patients Pattern Population Prostaglandin D2 Reaction Research Research Personnel Research Proposals Research Training Role STAT6 gene Sampling Scientist Severities Signal Transduction Sinus Sputum Structure of mucous membrane of nose Subgroup Symptoms Technology Testing Time Tissues Training Vocational Guidance Work airway epithelium airway inflammation antagonist anti-IgE aspirin-exacerbated respiratory disease asthmatic biobank career chemokine chronic rhinosinusitis clinical care clinical predictors cyclooxygenase 1 cytokine eosinophil in vivo inhibitor inter-institutional lipidomics medical specialties migration next generation novel patient oriented patient oriented research peripheral blood prevent profiles in patients recruit reduce symptoms respiratory response sample collection single-cell RNA sequencing standard of care statistics therapeutic target transcriptome transcriptomics treatment response

项目摘要

Abstract The overall goal of the proposed research is to identify novel aspects of human innate lymphoid cell (ILC) biology in airway diseases using patient-oriented research (POR) and through mentoring junior clinical investigators. The candidate has a strong record of mentoring individuals at many levels including clinical investigators in multiple specialties. The mentoring plan includes recruitment and training of fellow and faculty investigators from three disciplines (allergy, otolaryngology, and pulmonary) within the UCSD Center for Asthma and Sinus Disease center of excellence to foster the careers of junior investigators and perform outstanding POR. There are currently large gaps in our understanding of the roles of ILCs in human sinus disease and asthma which cause significant morbidity worldwide. ILCs are divided by the types of cytokines they secrete and ILC2s that secrete Th2 cytokines have been shown to promote airway inflammation in animal models. Importantly, recent work has shown that ILC2s are increased in samples from patients with asthma and chronic rhinosinusitis (CRS). Our group was the first to show that ILC2s are increased in a subgroup of nasal polyps in CRS that contain eosinophils and are also recruited to the nose after aspirin challenge in patients with aspirin-exacerbated respiratory disease (AERD). AERD patients have severe sinus disease with nasal polyps, moderate to severe asthma, and respiratory reactions to aspirin and similar compounds. In the current proposal, we will test the hypothesis that through the use of cutting-edge technology (single cell RNA-seq) we will be able to identify specific subgroups or “endotypes” of patients with CRS and asthma by tissue and blood ILC subset composition. We also posit that biologic blockade of type 2 inflammation in AERD, asthma and CRS patients will reduce ILC2 recruitment to the airway. Critically, this award will provide protected time for POR in sinus disease and asthma and allow for outstanding mentorship of the next generations of POR investigators.

摘要